Dar Al Dawa Development and Investment Co. (DAD)

Board of Directors Chairman : Mr. Nizar Jardaneh
General Manager: Mr. Mohammad Fityani
Paid Capital  $ 17,000,000 US
Personnel 600 employees
Company Classification Public shareholding
Certification ISO 9001, EU-GMP
Markets Jordan, Saudi Arabia, Algeria, United Emirates, Oman, Bahrain, Lebanon, Iraq, Kuwait, Yemen, Romania, Libya, Tunisia, Malta, Hong Kong, Malaysia, Sudan, Ethiopia, Somalia
Therapeutic Categories ntibiotics, Chemotherapeutics, Antimycotics, Dermatologicals, Anti-inflammatories and Analgesics, Antihemorrhoidals, Cardiovasculars, Gastrointestinals, Antidiabetics, Impotence therapy agents.
Central nervous system products
Ophthalmologicals/ otologicals/ nasals.
Respiratory products, Vitamins, Minerals, Antihistamines, Gonadotrophins, Mouth washes.
Licenses 10 products from Parke Davis
Address P.O. Box 9364, Amman, 11191 Jordan
Telephone ++ 962-6- 572-7132, ++962-6-553-9176
Fax ++ 962-6-572-7776, ++ 962-6-553-3199
E-mail admin.dad@dadgroup.com 
dad@go.com.jo 
sales.dad@dadgroup.com 
Web Site www.dadgroup.com